The Virus Project was organized by Altru Institute to foster collaboration among those focused on Infectious Diseases with the belief that increased collaboration among those working to find cures will accelerate progress.

The theory is that if the effectiveness can be increased by just few percentage points for all involved, the aggregated result will be significant. This effectiveness is made possible by the aggregation of high quality insight and information housed at this website. Organizations that the Virus Project supports:

Mirimus Clinical Labs is engaged in the design, development and pioneering of new genome editing technologies to develop animal models that are crucial for the preclinical evaluation of new therapeutics. They are revolutionizing the creation of animal models by synergzing RNAi and CRISPR/Cas9 technologies for development of mice, rats and higher organisms.

Lighthouse Lab Services provides comprehensive solutions to challenges facing the clinical laboratory community through recruiting, consulting, and buying and selling services.

Wynn Resorts is in the process of building its own on-site rapid Covid-19 testing lab at the Wynn Las Vegas, with plans to have the center up and running by Thanksgiving. The lab, which will have the ability to provide “thousands of accurate rapid tests daily,” is being built in partnership with the University Medical Center (UMC) of Southern Nevada. 

Rapid Tests is an all-volunteer group advocating for rapid tests to be made legal and widely available. We believe that these tests, if used properly, can allow us to safely reopen schools and the economy. The group is supported by a volunteer team of doctors, public health experts, animators, and many more.

The Balsa Group is a nonprofit Biotechnology and Life Science Advising Group  founded  by a group of biomedical PhD candidates and postdoctoral fellows from Washington University School of Medicine.  The goal of the group is to supplement academic training by providing real-world experience in the science of business and development of transferable professional skills to better prepare members for both academic and non-academic career paths. 

Coalition for Epidemic Preparedness Innovations is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious disease.


National Foundation for Infectious Diseases is one of the leading funders for research institutions globally. They have provided invaluable insight into the field of infectious diseases and are a resource for industry information.


The GISAID Initiative is widely credited for successfully enabling the rapid sharing of influenza virus data through a unique sharing mechanism, that was recognized for its importance to global health by all G20 health ministers.


International Federation of Pharmaceutical Manufacturers & Associations represents research-based biopharmaceutical companies, and regional and national associations across the world. They facilitate collaboration, dialogue, and understanding within industry and with other global players in the health community.